Quantcast

Latest Nicholas J. Vogelzang Stories

2013-09-25 11:02:09

Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone. The study, published Sept. 24 in Lancet Oncology, was led by Ethan Basch, MD, director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center. Researchers measured the pain and quality of life...

2013-04-10 23:02:57

ACF Welcomes Prominent Veterinary and Human Oncologists to its Scientific Advisory Council. The Council Advises the Executive Board on Comparative Oncology Award Grant Criteria and Evaluation. Norwalk, Connecticut (PRWEB) April 10, 2013 Animal Cancer Foundation (ACF) has appointed several prominent leaders in the veterinary and human oncology field to serve as Scientific Advisory Council to its Executive Board. (http://www.acfoundation.org/about/council.php) The Scientific Advisory...

2013-04-04 12:16:56

Despite menopause-like side effects, continuous hormone treatment is superior to intermittent therapy A study published today in the New England Journal of Medicine recommends a dramatic shift in the way doctors treat metastatic prostate cancer. "These results have changed the way I treat patients," said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio and senior author on the international...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related